As of 2025-09-15, the Relative Valuation of Pacira Biosciences Inc (PCRX) is (88.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.12 USD, the upside of Pacira Biosciences Inc based on Relative Valuation is -426.6%.
The range of the Relative Valuation is (87.83) - (98.04) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.0x - 43.9x | 35.6x |
| Forward P/E multiples | 20.4x - 34.6x | 26.9x |
| Fair Price | (87.83) - (98.04) | (88.58) |
| Upside | -423.9% - -461.5% | -426.6% |
| Date | P/E |
| 2025-09-11 | -9.53 |
| 2025-09-10 | -9.38 |
| 2025-09-09 | -9.27 |
| 2025-09-08 | -9.43 |
| 2025-09-05 | -9.32 |
| 2025-09-04 | -9.42 |
| 2025-09-03 | -9.58 |
| 2025-09-02 | -9.60 |
| 2025-08-29 | -9.40 |
| 2025-08-28 | -9.46 |
| 2025-08-27 | -9.21 |
| 2025-08-26 | -9.16 |
| 2025-08-25 | -8.94 |
| 2025-08-22 | -9.11 |
| 2025-08-21 | -8.95 |
| 2025-08-20 | -8.81 |
| 2025-08-19 | -8.88 |
| 2025-08-18 | -8.77 |
| 2025-08-15 | -8.74 |
| 2025-08-14 | -8.81 |
| 2025-08-13 | -8.83 |
| 2025-08-12 | -8.75 |
| 2025-08-11 | -8.88 |
| 2025-08-08 | -8.88 |
| 2025-08-07 | -8.38 |
| 2025-08-06 | -7.90 |
| 2025-08-05 | -7.95 |
| 2025-08-04 | -8.09 |
| 2025-08-01 | -7.78 |
| 2025-07-31 | -7.43 |
| 2025-07-30 | -7.67 |
| 2025-07-29 | -7.62 |
| 2025-07-28 | -7.77 |
| 2025-07-25 | -7.95 |
| 2025-07-24 | -7.69 |
| 2025-07-23 | -7.84 |
| 2025-07-22 | -7.91 |
| 2025-07-21 | -7.81 |
| 2025-07-18 | -7.61 |
| 2025-07-17 | -7.86 |
| 2025-07-16 | -7.97 |
| 2025-07-15 | -8.01 |
| 2025-07-14 | -8.22 |
| 2025-07-11 | -8.07 |
| 2025-07-10 | -8.35 |
| 2025-07-09 | -8.17 |
| 2025-07-08 | -8.17 |
| 2025-07-07 | -8.19 |
| 2025-07-03 | -8.19 |
| 2025-07-02 | -8.18 |